Home
Flashcards
Preview
Hematology
Home
Get App
Take Quiz
Create
Clotting Process: 2 pathways
intrinsic and extrinsic pathway: factors activated by heparin and vitamin K dependent (Coumadin works there)
intrinsic system
requires certain clotting factors and calcium. activated by irritation or damage of endothelium (thrombophlebitis)
extrinsic system
clotting time is less bc body needs to hurridly clot the laceration or damaged tissue; requres thromboplastin
anticoagulants
retard the clotting process. they DO NOT dissolve already formed clots, just PREVENT clots.
pt. teaching
: minimize risk for injury
Used primarily for prevention of clots in veins? (DVTs)
Heparin for
initial
anticoagulation;
Coumadin for
maintainence
Heparin
can't be given orally since it can't cross the GI tract
1. thrombocytopenia
2. thromboembolism
1. decrease in platelets--->bleeding
2. thromboembolism--->small clots
ANTIDOTE: for heparin
protamine sulfate
if
active hemorrhage
labs to monitor
APTT (activated partial thromboplastin time)
Normal APTT=40 sec.
Therapeutic if 1.5-2X normal (60-80) (on sliding scale)
low-molecular heparins
don't require APTT monitoring
most commonly used in orthopedic surgery
recommended in acute coronary syndrome
"parin" family
enoxa
parin
(Lovenox)
Warfarin (Coumadin)
used as a rat killer
works on Vitamin K-dependent factors
maintenance anticoagulation drug
used for pre-a-fib, MI, artificial heart valve
primary SE of Coumadin
hemorrhage
ANTIDOTE:
Vitamin K
pt shouldn't eat too many green leafy vegis (spinach, etc.) since it contains vitamin K
Labs to monitor
PT (prothrombin time-normal is 12)
Therapeutic level
is 1 1/2X normal (18)
or
INR w/ therapeutic level 2-3
anti-platelet aggregates
prevent
arteriole
clots
thromboxane A2 inhibitors
bind to COX-1 receptors
Aspirin-82 mg recommended for pts w/ MI & stroke risk
325 mg dose recommended as 1st line drug in management of pt w/ MI
BP needs to be
no more
than 150/90
ibuprofin & aspirin
shouldn't be taken together
long term
adenosine diphosphate receptor antagonists
prevent aggregation w/ irreversible blockade on platelets
used in pt who had a stroke or risk for stroke
cardic cath pt
: clopidrogel (Plavix)
glycoprotein IIb/IIIa receptor antagonists
block those receptors thereby preventing aggregation
most commonly used in acute coranary syndrome
abciximab (Reopro)
Fibrinolytics
"clot busters"
primarily used in immediate MI
"ase" enzymes (form of tPA)
nurse determine
: stroke bc of clot in vessel
OR
stroke bc of bleeding in brain
before
administering drug
General criteria for fibrinolytics
window of opportunity
: 6 hrs from onset (of symptoms for heart)
3-4.5 hrs for stroke
over 80 y/o w/ previous hx stroke & DM
: 3 hrs
no active bleeding-pt on Coumadin can get it but within 3 hr window & INR <1.7
no major trauma/surgery within last few months
anti-fibrinolytic or hemostatic agents
promote
clot formation
used to stop excessive bleeding
blood
don't give it unless hemoglobin <10 g/dL
whole blood not usually givven (usually just certain component)
cyroprecipitate "cryo"
precpitate after thaw plasma
: fibrinogen
albumin
: increases colloid osmotic pressure
anemia
"ferrous"
: iron
vitamin C enhances absorption
antacids reduce absorption
hematopoietic agents
stimulates bone marrow to produce blood cells
WBC stimulation
"grastim" drugs
platelet stimulation-- Neumaga
Author
Christyna
ID
45191
Card Set
Hematology
Description
hematology unit
Updated
2010-10-26T21:32:41Z
Show Answers
Home
Flashcards
Preview